Metastasis suppressor NME1 promotes non-homologous end joining of DNA double-strand breaks.

DNA Repair (Amst)

State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences Beijing, Beijing Institute of Lifeomics, Beijing 102206, China; Department of Biochemistry and Molecular Medicine, The George Washington University School of Medicine and Health Science, 2300 Eye Street, N.W., Washington, DC, 20037, USA; George Washington University Cancer Center, Washington, DC, 20052, USA; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430062, China. Electronic address:

Published: May 2019

NME1 (also known as NM23-H1) was the first identified tumor metastasis suppressor, which has been reported to link with genomic stability maintenance and cancer. However its underlying mechanisms are still not fully understood. Here we find that NME1 is required for non-homologous end joining (NHEJ) of DNA double-strand breaks (DSBs). Mechanistically, NME1 re-localizes to DNA damage sites in a Ku-XRCC4-dependent manner, and regulates downstream LIG4 recruitment and end joining efficiency. Furthermore, we show that the 3'-5' exonuclease activity of NME1 is critical for its function in NHEJ. Taken together, our findings identify NME1 as a novel NHEJ factor, and reveal how this metastasis suppressor promotes genome stability.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dnarep.2019.03.003DOI Listing

Publication Analysis

Top Keywords

metastasis suppressor
12
non-homologous joining
8
dna double-strand
8
double-strand breaks
8
nme1
6
suppressor nme1
4
nme1 promotes
4
promotes non-homologous
4
joining dna
4
breaks nme1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!